Phenazopyridine Hydrochloride
Product Images NDC 66116-484

2 FDA label images from Medvantx, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phenazopyridine Hydrochloride (NDC 66116-484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

32b5816d-figure-01 (A63d3ace 768f 4e1b A5e9 Dad1817453b9 01)

32b5816d-figure-01 (A63d3ace 768f 4e1b A5e9 Dad1817453b9 01)
Chemical structure of Phenazopyridine Hydrochloride, showing the molecular arrangement including a pyridine ring with amino groups and an azo linkage to a benzene ring with a hydrochloride component.*
FDA Label Image

Phenazopyridine 200mg Tablets (A63d3ace 768f 4e1b A5e9 Dad1817453b9 02)

Phenazopyridine 200mg Tablets (A63d3ace 768f 4e1b A5e9 Dad1817453b9 02)
The label for Phenazopyridine Hydrochloride Tablets, USP 200mg, shows a package of 6 tablets from MedVantx, Inc. It includes dosage instructions to see the package insert, storage conditions (20°-25°C with excursions permitted), and warnings for Rx only and sample not for sale. Manufacturer information for Amneal Pharmaceuticals in Paterson, NJ, and distributor details for MedVantx in San Diego, CA, are provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.